Omar Faruq, Deepak Iyer, Patrick Wang, Mariusz Shrestha, Cuihong Wei, Aaron D. Schimmer et al. CD47 promotes myeloma cell growth through JAK–STAT3/MYC signalling and is targetable by ruxolitinib. // British Journal of Haematology. – 2026. – DOI: 10.1111/bjh.70736. – URL: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70736?af=R
Omar Faruq, Deepak Iyer, Patrick Wang, Mariusz Shrestha, Cuihong Wei, Aaron D. Schimmer, & Hong Chang (2026). CD47 promotes myeloma cell growth through JAK–STAT3/MYC signalling and is targetable by ruxolitinib. British Journal of Haematology. https://doi.org/10.1111/bjh.70736
Omar Faruq, et al. “CD47 promotes myeloma cell growth through JAK–STAT3/MYC signalling and is targetable by ruxolitinib.” British Journal of Haematology, 2026. doi:10.1111/bjh.70736.
@article{Faruq2026,
title = {CD47 promotes myeloma cell growth through JAK–STAT3/MYC signalling and is targetable by ruxolitinib},
author = {Faruq, Omar and Iyer, Deepak and Wang, Patrick and Shrestha, Mariusz and Wei, Cuihong and Schimmer, Aaron D. and Chang, Hong},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70736},
url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.70736?af=R}
}